Rick Davis

1.9k total citations
25 papers, 1.5k citations indexed

About

Rick Davis is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Psychiatry and Mental health. According to data from OpenAlex, Rick Davis has authored 25 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Psychiatry and Mental health. Recurrent topics in Rick Davis's work include Electroconvulsive Therapy Studies (4 papers), Antibiotic Resistance in Bacteria (3 papers) and Blood Pressure and Hypertension Studies (3 papers). Rick Davis is often cited by papers focused on Electroconvulsive Therapy Studies (4 papers), Antibiotic Resistance in Bacteria (3 papers) and Blood Pressure and Hypertension Studies (3 papers). Rick Davis collaborates with scholars based in United States, Australia and New Zealand. Rick Davis's co-authors include Harriet M. Bryson, Anthony Markham, Julia A. Balfour, Donna McTavish, Ruth Whittington, David H. Peters, Michelle I. Wilde, Diana Faulds, Jane C. Gillis and Heather D. Langtry and has published in prestigious journals such as Applied and Environmental Microbiology, Drugs and CNS Drugs.

In The Last Decade

Rick Davis

22 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rick Davis United States 14 470 335 293 207 204 25 1.5k
William A. Wargin United States 23 408 0.9× 500 1.5× 319 1.1× 150 0.7× 249 1.2× 54 1.9k
Steven Troy United States 19 494 1.1× 218 0.7× 143 0.5× 140 0.7× 217 1.1× 49 1.3k
H. Friedman United States 24 341 0.7× 204 0.6× 156 0.5× 149 0.7× 121 0.6× 53 1.3k
Heather D. Langtry New Zealand 24 358 0.8× 292 0.9× 158 0.5× 262 1.3× 391 1.9× 31 2.2k
Timi Edeki United States 19 450 1.0× 336 1.0× 184 0.6× 230 1.1× 180 0.9× 41 1.6k
Pascale Jolliet France 29 659 1.4× 283 0.8× 224 0.8× 326 1.6× 413 2.0× 165 2.7k
Nicolas Simon France 31 663 1.4× 275 0.8× 382 1.3× 390 1.9× 417 2.0× 146 2.6k
G.J. Krol United States 18 398 0.8× 143 0.4× 152 0.5× 152 0.7× 190 0.9× 37 1.1k
S. A. Kaplan United States 20 465 1.0× 234 0.7× 287 1.0× 189 0.9× 288 1.4× 42 1.7k
Arthur B. Straughn United States 26 378 0.8× 460 1.4× 373 1.3× 106 0.5× 204 1.0× 71 2.1k

Countries citing papers authored by Rick Davis

Since Specialization
Citations

This map shows the geographic impact of Rick Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick Davis more than expected).

Fields of papers citing papers by Rick Davis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rick Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick Davis. The network helps show where Rick Davis may publish in the future.

Co-authorship network of co-authors of Rick Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Rick Davis. A scholar is included among the top collaborators of Rick Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rick Davis. Rick Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cicali, Emily J., Cameron D. Thomas, Rachel Dalton, et al.. (2023). Implementation of CYP2C19 genotyping to guide proton pump inhibitor use at an academic health center. American Journal of Health-System Pharmacy. 80(15). 994–1003. 12 indexed citations
2.
Davis, Rick, et al.. (2016). A case of massive aortic mural thrombus in the absence of atherosclerotic or aneurysmal disease. IJC Heart & Vasculature. 12. 82–84. 5 indexed citations
3.
Maroko, Peter R., Laurence W.V. DeBoer, & Rick Davis. (2015). Infarct Size Reduction: A Critical Review. Advances in cardiology. 27. 127–169.
4.
Davis, Rick, Ruth Whittington, & Harriet M. Bryson. (1997). Nefazodone. Drugs. 53(4). 608–636. 117 indexed citations
5.
Davis, Rick & Diana Faulds. (1997). Nadroparin Calcium. Drugs & Aging. 10(4). 299–322. 20 indexed citations
6.
Langtry, Heather D., Jane C. Gillis, & Rick Davis. (1997). Topiramate. Drugs. 54(5). 752–773. 112 indexed citations
7.
Davis, Rick & Anthony Markham. (1997). Ziprasidone. CNS Drugs. 8(2). 153–159. 21 indexed citations
8.
Davis, Rick, Allan J. Coukell, & Donna McTavish. (1997). Fosinopril. Drugs. 54(1). 103–116. 15 indexed citations
9.
Davis, Rick & Michelle I. Wilde. (1996). Sertraline. PharmacoEconomics. 10(4). 409–431. 30 indexed citations
10.
Davis, Rick, Anthony Markham, & Julia A. Balfour. (1996). Ciprofloxacin. Drugs. 51(6). 1019–1074. 333 indexed citations
11.
Wagstaff, Antona J., Rick Davis, & Donna McTavish. (1996). Fosinopril. Drugs. 51(5). 777–791. 21 indexed citations
12.
Davis, Rick & Michelle I. Wilde. (1996). Mirtazapine. CNS Drugs. 5(5). 389–402. 108 indexed citations
13.
Davis, Rick & Diana Faulds. (1996). Dexfenfluramine. Drugs. 52(5). 696–724. 82 indexed citations
14.
Davis, Rick & Ruth Whittington. (1995). Aprotinin. Drugs. 49(6). 954–983. 84 indexed citations
15.
Davis, Rick, Yvonne E. Yarker, & Karen L. Goa. (1995). Diclofenac/Misoprostol. Drugs & Aging. 7(5). 372–393. 11 indexed citations
16.
Davis, Rick & Donna McTavish. (1995). Budesonide. PharmacoEconomics. 7(5). 457–470. 13 indexed citations
17.
Bittner, H, et al.. (1995). Right ventricular dysfunction in the brain-dead heart-beating organ donor.. PubMed. 27(4). 2551–5. 2 indexed citations
18.
Davis, Rick & Harriet M. Bryson. (1994). Levofloxacin. Drugs. 47(4). 677–700. 286 indexed citations
19.
Davis, Rick & Harriet M. Bryson. (1994). Ceftriaxone. PharmacoEconomics. 6(3). 249–269. 14 indexed citations
20.
Davis, Rick, David H. Peters, & Donna McTavish. (1994). Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy.. PubMed. 47(2). 332–72. 235 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William A. Wargin Breakdown of academic impact, for papers by Steven Troy Breakdown of academic impact, for papers by H. Friedman Breakdown of academic impact, for papers by Heather D. Langtry Breakdown of academic impact, for papers by Timi Edeki Breakdown of academic impact, for papers by Pascale Jolliet Breakdown of academic impact, for papers by Nicolas Simon Breakdown of academic impact, for papers by G.J. Krol Breakdown of academic impact, for papers by S. A. Kaplan Breakdown of academic impact, for papers by Arthur B. Straughn
Rankless by CCL
2026